mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn’s Disease
Authors:
- Federica UngaroFUFederica Ungaro
- Valentina GarlattiVGValentina Garlatti
- Luca MassiminoLMLuca Massimino
- Antonino SpinelliASAntonino Spinelli
- Michele CarvelloMCMichele Carvello
- Matteo SacchiMSMatteo Sacchi
- Salvatore SpanòSSSalvatore Spanò
- Gaia ColasanteGCGaia Colasante
- Nicholas ValassinaNVNicholas Valassina
- Stefania VetranoSVStefania Vetrano
- Alberto MalesciAMAlberto Malesci
- Laurent Peyrin-BirouletLaurent Peyrin-Biroulet
Open Access
Abstract
Crohn’s disease (CD) is a chronic inflammatory condition that can affect different portions of the gastrointestinal tract. Lymphatic drainage was demonstrated to be dysfunctional in CD pathogenesis, ultimately causing the failure of the resolution of intestinal inflammation. To investigate the molecular mechanisms underlying these dysfunctions, we isolated human intestinal lymphatic endothelial cells (HILECs) from surgical specimens of patients undergoing resection for complicated CD (CD HILEC) and from a disease-free margin of surgical specimens of patients undergoing resection for cancer (healthy HILEC). Both cell types underwent transcriptomic profiling, and their barrier functionality was tested using a transwell-based co-culture system between HILEC and lamina propria mononuclear cells (LPMCs). Results showed CD HILEC displayed a peculiar transcriptomic signature that highlighted mTOR signaling as an orchestrator of leukocyte trafficking through the lymphatic barrier of CD patients. Moreover, we demonstrated that LPMC transmigration through the lymphatic endothelium of patients with CD depends on the capability of mTOR to trigger interleukin 20 receptor subunit α (IL20RA)-mediated intracellular signaling. Conclusively, our study suggests that leukocyte trafficking through the intestinal lymphatic microvasculature can be controlled by modulating IL20RA, thus leading to the resolution of chronic inflammation in patients with CD.Keywords
Funding Information
- Ministero della Salute (RBFR12VP3Q_002 and GR-2011-02348069)
- Innovative Medicines Initiative (Joint Undertaking BTCure (115142))
This publication has 35 references indexed in Scilit:
- Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11International Journal of Cancer, 2019
- The colonic epithelium plays an active role in promoting colitis by shaping the tissue cytokine profilePLOS Biology, 2018
- MFSD2A Promotes Endothelial Generation of Inflammation-Resolving Lipid Mediators and Reduces Colitis in MiceGastroenterology, 2017
- IL-7 Restores T Lymphocyte Immunometabolic Failure in Septic Shock Patients through mTOR ActivationThe Journal of Immunology, 2017
- Exploiting lymphatic vessels for immunomodulation: Rationale, opportunities, and challengesAdvanced Drug Delivery Reviews, 2017
- T Cell Trafficking through Lymphatic VesselsFrontiers in Immunology, 2016
- Dendritic Cell Migration Through the Lymphatic Vasculature to Lymph Nodes2013
- Pharmacological Control of Autophagy: Therapeutic Perspectives in Inflammatory Bowel Disease and Colorectal CancerCurrent Pharmaceutical Design, 2012
- IL-20 activates human lymphatic endothelial cells causing cell signalling and tube formationMicrovascular Research, 2009
- IL-19 and IL-20: two novel cytokines with importance in inflammatory diseasesExpert Opinion on Therapeutic Targets, 2007